Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

IStar Systematic Fund up 3.63% YTD after returning 3.24% in 2012

Wednesday, April 03, 2013
Opalesque Industry Update – The IStar Systematic Fund, backed by seeding specialist IMQubator, reconfigured its trading strategy in April, 2012, and turned a negative performance into a positive return for the year, ending up at +3.24% at the end of December, 2012*.

The Fund is now up 3.63% for 2013 (to end February)*, versus a YTD average of 0.77% for managed future funds as a whole, according to the Barclay CTA Index compiled by BarclayHedge. In the last 12 months, IStar Systematic has returned 8.58% with a Sharpe ratio of 1.1.*

The IStar Systematic Fund is a Luxembourg-registered SICAV SIF, providing CTA/Managed Futures style hedge fund strategies across 50 markets, relying on behavioural economics research and the extensive experience of the principals. The company behind it, Amsterdam-based Istar Capital BV, was set up by AIG veterans Rudolph Shally and Thomas Artarit, who have nearly 45 years combined experience in the financial industry.

The IStar fund employs several multi sub-strategies and discretionary risk management rules applied on systematic signals, so it’s a “hybrid product between divergence and convergence” that seeks to generate alpha in all market conditions.

In May 2011, IStar Capital signed a seed investment deal with IMQubator, the hedge fund seeding platform backed by APG, the asset manager for Dutch pensions giant Stichting Pensioenfonds ABP.

IStar’s Co-CEO and Founding Partner, Thomas Artarit, comments: “In an environment where the safest bonds are yielding so little, CTAs have a receptive audience. Pension funds and institutions desperate to diversify out of fixed income but uncomfortable with the volatility suffered by equities are the natural market. The value of CTAs is in long-term, statistical out-performance: they truly pay off in the long haul.”

* source: Bloomberg.

Press release

www.istarcapital.com

Opalesque Note: IStar's two founders Thomas Artarit and Rudolph Shally recently talked to Opalesque TV about trend following .

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its